Advertisement

Digestive Diseases and Sciences

, Volume 63, Issue 12, pp 3290–3296 | Cite as

Patient and Caregiver Attitudes and Practices of Exercise in Candidates Listed for Liver Transplantation

  • David M. ChascsaEmail author
  • Jennifer C. Lai
  • Michael A. Dunn
  • Aldo J. Montano-Loza
  • Matthew R. Kappus
  • Srinivasan Dasarathy
  • Elizabeth J. Carey
Original Article

Abstract

Background

Impaired physical capacity increases peri-liver transplant complications. Patient perceptions regarding exercise prior to transplantation are not known.

Aims

This study aimed to assess patient and caregiver activity levels, perceptions of willingness to exercise, and of provider advice.

Methods

Consecutive patients listed for liver transplant and caregivers presenting for routine outpatient visits were evaluated over a 3-month interval. Anonymous surveys adapted to patients and caregivers addressed the importance and safety of exercise, type and duration of exercise performed, barriers, willingness to wear a monitoring device, and perceived provider recommendations. Responses were logged on a Likert scale from 1 to 5.

Results

Three hundred and sixty-eight responses were received. Most participants perceived exercise as important. Patients exercised three times per week for 30 min. Eighty percent endorsed walking (median response: 2—agree; IQR 1–2). Most did not jog, swim, cycle, or strength train. Fatigue, reported by 70%, was the major barrier (2, IQR 1–3). Over 90% of caregivers endorsed exercise as important (1—strongly agree, IQR 1–2) and encouraged exercise (median response 2, IQR 1–2). Over 60% of patients (median response 2, IQR 1–3) and caregivers (median response 2, IQR 2–3) felt providers encouraged exercise.

Conclusions

Patients and caregivers are willing to exercise to optimize physical fitness prior to liver transplantation.

Keywords

Physical capacity Exercise Liver transplantation Patient Caregiver 

Abbreviations

FLEXIT

Fitness, life enhancement, and exercise in transplantation

LT

Liver transplant

MELD

Model for end-stage liver disease

Notes

Author’s contributions

J. Lai, M. Dunn, A. Montano-Loza, M. Kappus, and E. Carey designed the study, collected the data, and provided significant input regarding manuscript composition. D. Chascsa analyzed the data and composed the manuscript. S. Dasarathy assisted in study design and provided significant input regarding manuscript composition.

Funding

Funding was provided by National Institute on Aging (Grant No. K23AG048337).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

10620_2018_5271_MOESM1_ESM.docx (62 kb)
Supplementary material 1 (DOCX 62 kb)
10620_2018_5271_MOESM2_ESM.docx (60 kb)
Supplementary material 2 (DOCX 59 kb)

References

  1. 1.
    Kim HY, Jang JW. Sarcopenia in the prognosis of cirrhosis: going beyond the MELD score. World J Gastroenterol. 2015;21:7637–7647.CrossRefGoogle Scholar
  2. 2.
    Carey EJ. Sarcopenia in solid organ transplantation. Nutr Clin Pract. 2014;29:159–170.CrossRefGoogle Scholar
  3. 3.
    Lai JC, Feng S, Terrault NA, Lizaola B, Hayssen H, Covinsky K. Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant. 2014;14:1870–1879.CrossRefGoogle Scholar
  4. 4.
    Carey EJ, Steidley DE, Aqel BA, et al. Six-minute walk distance predicts mortality in liver transplant candidates. Liver Transpl. 2010;16:1373–1378.CrossRefGoogle Scholar
  5. 5.
    Dunn MA, Josbeno DA, Tevar AD, et al. Frailty as tested by gait speed is an independent risk factor for cirrhosis complications that require hospitalization. Am J Gastroenterol. 2016;111:1768–1775.CrossRefGoogle Scholar
  6. 6.
    Englesbe MJ, Patel SP, He K, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg. 2010;211:271–278.CrossRefGoogle Scholar
  7. 7.
    Lai JC, Dodge JL, Sen S, Covinsky K, Feng S. Functional decline in patients with cirrhosis awaiting liver transplantation: results from the functional assessment in liver transplantation (FrAILT) study. Hepatology. 2016;63:574–580.CrossRefGoogle Scholar
  8. 8.
    Montano-Loza AJ. Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation. Liver Transpl. 2014;20:1424.CrossRefGoogle Scholar
  9. 9.
    Montano-Loza AJ, Meza-Junco J, Prado CM, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10:166–173 e161.CrossRefGoogle Scholar
  10. 10.
    Tandon P, Low G, Mourtzakis M, et al. A model to identify sarcopenia in patients with cirrhosis. Clin Gastroenterol Hepatol. 2016;14:1473–1480 e1473.CrossRefGoogle Scholar
  11. 11.
    Tandon P, Tangri N, Thomas L, et al. A rapid bedside screen to predict unplanned hospitalization and death in outpatients with cirrhosis: a prospective evaluation of the clinical frailty scale. Am J Gastroenterol. 2016;111:1759–1767.CrossRefGoogle Scholar
  12. 12.
    Tsien C, Garber A, Narayanan A, et al. Post-liver transplantation sarcopenia in cirrhosis: a prospective evaluation. J Gastroenterol Hepatol. 2014;29:1250–1257.CrossRefGoogle Scholar
  13. 13.
    Kaido T, Ogawa K, Fujimoto Y, et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant. 2013;13:1549–1556.CrossRefGoogle Scholar
  14. 14.
    Kalafateli M, Mantzoukis K, Choi Yau Y, et al. Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the model for end-stage liver disease score. J Cachexia Sarcopenia Muscle. 2016;8:113–121.CrossRefGoogle Scholar
  15. 15.
    Montano-Loza AJ. Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol. 2014;20:8061–8071.CrossRefGoogle Scholar
  16. 16.
    Tandon P, Ney M, Irwin I, et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl. 2012;18:1209–1216.CrossRefGoogle Scholar
  17. 17.
    Dunn MA, Josbeno DA, Schmotzer AR, et al. The gap between clinically assessed physical performance and objective physical activity in liver transplant candidates. Liver Transpl. 2016;22:1324–1332.CrossRefGoogle Scholar
  18. 18.
    Kappus MR, Mendoza MS, Nguyen D, Medici V, McClave SA. Sarcopenia in patients with chronic liver disease: can it be altered by diet and exercise? Curr Gastroenterol Rep. 2016;18:43.CrossRefGoogle Scholar
  19. 19.
    Kutner NG, Zhang R, Bowles T, Painter P. Pretransplant physical functioning and kidney patients’ risk for posttransplantation hospitalization/death: evidence from a national cohort. Clin J Am Soc Nephrol. 2006;1:837–843.CrossRefGoogle Scholar
  20. 20.
    Mathur S, Janaudis-Ferreira T, Wickerson L, et al. Meeting report: consensus recommendations for a research agenda in exercise in solid organ transplantation. Am J Transplant. 2014;14:2235–2245.CrossRefGoogle Scholar
  21. 21.
    Dasarathy S. Consilience in sarcopenia of cirrhosis. J Cachexia Sarcopenia Muscle. 2012;3:225–237.CrossRefGoogle Scholar
  22. 22.
    Garcia-Pagan JC, Santos C, Barbera JA, et al. Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology. 1996;111:1300–1306.CrossRefGoogle Scholar
  23. 23.
    Carey EJ, Lai JC, Wang CW, et al. A multicenter study to define sarcopenia in patients with end-stage liver disease. Liver Transpl. 2017;23:625–633.CrossRefGoogle Scholar
  24. 24.
    Bandi JC, Garcia-Pagan JC, Escorsell A, et al. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis. Hepatology. 1998;28:677–682.CrossRefGoogle Scholar
  25. 25.
    Berzigotti A, Albillos A, Villanueva C, et al. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the sportdiet study. Hepatology. 2016;65:1293–1305.CrossRefGoogle Scholar
  26. 26.
    Macias-Rodriguez RU, Ilarraza-Lomeli H, Ruiz-Margain A, et al. Changes in hepatic venous pressure gradient induced by physical exercise in cirrhosis: results of a pilot randomized open clinical trial. Clin Transl Gastroenterol. 2016;7:e180.CrossRefGoogle Scholar
  27. 27.
    Duarte-Rojo A, Ruiz-Margain A, Montano-Loza AJ, Macias-Rodriguez RU, Ferrando A, Kim WR. Exercise and physical activity for patients with end-stage liver disease: improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl. 2018;24:122–139.CrossRefGoogle Scholar
  28. 28.
    Silveira MG, Gossard AA, Stahler AC, et al. A randomized, placebo-controlled clinical trial of efficacy and safety: modafinil in the treatment of fatigue in patients with primary biliary cirrhosis. Am J Ther. 2017;24:e167–e176.CrossRefGoogle Scholar
  29. 29.
    Talwalkar JA, Donlinger JJ, Gossard AA, et al. Fluoxetine for the treatment of fatigue in primary biliary cirrhosis: a randomized, double-blind controlled trial. Dig Dis Sci. 2006;51:1985–1991.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Gastroenterology and HepatologyMayo Clinic in ArizonaPhoenixUSA
  2. 2.Division of Gastroenterology and HepatologyUniversity of California San FranciscoSan FranciscoUSA
  3. 3.Center for Liver Diseases, Pittsburgh Liver Research Center and Thomas E. Starzl Transplantation InstituteUniversity of PittsburghPittsburghUSA
  4. 4.Division of Gastroenterology and Liver UnitUniversity of AlbertaEdmontonCanada
  5. 5.Division of Gastroenterology and HepatologyDuke UniversityDurhamUSA
  6. 6.Division of Gastroenterology and HepatologyCleveland ClinicClevelandUSA

Personalised recommendations